NCT04958187View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2021

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Hemodialysis
Interventions
DRUG

ANG-3777

Arm assigned to this intervention will receive 2 mg/kg, IV

Trial Locations (1)

55415

Hennepin County Medical Center (HCMC), Minneapolis

Sponsors

Collaborators (1)

Nucleus Network Ltd
All Listed Sponsors
collaborator

Nucleus Network Ltd

OTHER

lead

Angion Biomedica Corp

INDUSTRY

NCT04958187 - Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects | Biotech Hunter | Biotech Hunter